Cite
HARVARD Citation
Bonnet-Serrano, F. et al. (2022). Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients. European journal of endocrinology. 187 (2), pp. 315-322. [Online].